Mounjaro Other Names: Tirzepatide and Related Brands (October 2026)

01 · The short answer

Which names mean the same medicine as Mounjaro?

Only two names describe the same product: Mounjaro and tirzepatide. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly.¹ In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

If a pharmacy, article or friend says 'tirzepatide', they mean the active ingredient inside Mounjaro. If they say 'the pen' or 'the KwikPen', they mean the delivery device. None of these is a different treatment. You can read a fuller list of terms on our guide to Mounjaro alternative names.

02 · Your next step

What should you do with this information?

First, decide whether you are researching the medicine or trying to find a cheaper or different product. If you are researching, the useful takeaway is that there is no hidden second brand of the same drug in the UK to shop around for. The licensed product is Mounjaro, supplied as tirzepatide in a KwikPen.

Second, if you are after a different medicine because of tolerance, cost or availability, that is a prescriber conversation, not a naming question. Different medicines have different mechanisms and different licensed uses. Our page on Mounjaro other options walks through the alternatives that exist.

Third, be wary of anything that borrows the name. Sellers use 'tirzepatide' as a keyword for unlicensed products. Mounjaro must not be combined with other GLP-1 medicines, unlicensed 'research' peptides (such as retatrutide, which has no UK licence), or compounded copies. These combinations have no safety data and no regulated supply chain.¹ If something promises faster results outside a licensed pathway, that is the warning sign.

If you have decided the genuine product is right for you, you can start with a free online consultation reviewed by a GPhC-registered prescriber on the Mounjaro pen page, where current prices are shown live. We are GPhC-registered (9012878) and supply through official LillyDirect, so you receive genuine KwikPens direct from Eli Lilly's UK distribution. For the wider picture of treatment options, see our weight loss clinic.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

03 · Tirzepatide: the generic name

Tirzepatide: the generic name for Mounjaro

Tirzepatide is the generic name, meaning the name of the active ingredient, and it is the most common answer to 'what is another name for Mounjaro?'. Mounjaro is simply the brand name Eli Lilly uses for tirzepatide in the UK.¹ When a clinical paper, the BNF or a prescriber writes tirzepatide, they are describing the same medicine you may know by its brand.

Generic names matter because they stay constant while brand names change from country to country and company to company. A trial publication will always refer to tirzepatide. A leaflet or product page will usually use the brand. Knowing both lets you follow the research and the pharmacy listing without confusion.

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That dual action is what distinguishes it from single-action GLP-1 medicines such as semaglutide.

Because the generic name describes the active ingredient, the results from the major trials apply to the genuine medicine whichever name is printed on the paperwork. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

The trial figures belong to the licensed medicine used under supervision. They do not transfer to an unlicensed vial or a compounded product sold under the same generic word. A seller who writes 'tirzepatide' on a label has not thereby given you the tested, regulated product.

One practical point on how long the name stays relevant. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ That is useful to know if you are comparing products or switching between them, because the active ingredient from your last pen is still present for some time.

If you want a quick-reference list of related terms, our page on the other name for Mounjaro covers the same ground in a shorter format.

04 · Brand name and KwikPen

Mounjaro, KwikPen and the six strengths

Mounjaro is the brand and the KwikPen is the pen it is supplied in, so the two terms often appear together and are sometimes mistaken for separate products. The KwikPen is a pre-filled multi-dose pen. It is not a different formulation, and it is not a lower or higher grade of the drug.¹

The pen comes in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. People sometimes treat these as different 'names' for the medicine, for example calling it 'the 5' or 'the 10'. These are simply the dose strengths.

Treatment usually starts low and steps up. After at least 4 weeks the dose can step up to the next strength, depending on how you respond, as your prescriber advises. Your prescriber decides your maintenance dose based on how you respond and tolerate treatment.

Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Unopened pens should be stored in the fridge at 2–8°C until first use and keep until the printed expiry date.¹³ For anything beyond that, the patient information leaflet is the authority. Follow the pen's own instructions for how to inject.

Why does this matter for naming? Because retail listings sometimes describe a pack by its strength alone, or by phrases like 'weekly pen' or 'weight loss jab'. These are descriptions, not other brands. If a listing does not show Mounjaro or tirzepatide and the strength, you cannot be sure what you are looking at.

Our service supplies genuine KwikPens through official LillyDirect, with all six strengths stocked, and availability is shown live: all six doses are in stock. A pen at the starting strength costs £169.99, and a new customer's first 2.5mg pen is £129.99 with code FIRST40. You can see every strength on the Mounjaro pen page.

For a deeper look at which brand-style terms exist, our guide to Mounjaro other brands explains why the answer in the UK is shorter than many people expect.

05 · Ozempic and Wegovy: not the same

Ozempic and Wegovy: different medicines, not other names

Ozempic and Wegovy are not other names for Mounjaro. They are brands of semaglutide, a different active ingredient from a different company. Tirzepatide activates two receptors, GIP and GLP-1, while semaglutide is a single-action GLP-1 medicine.¹ This is the core reason the answer to 'Is Ozempic and Mounjaro the same?' is no.

They have separate product information, separate dosing and separate trial programmes.

Wegovy is the semaglutide product licensed for weight management. Its pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly. Titration steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17, and 2.4mg is the licensed maintenance dose for weight management.¹⁸ Mounjaro's strengths use a different scale altogether, so milligram numbers cannot be compared across the two products.

Trial results follow the same rule. The STEP 1 trial studied semaglutide and SURMOUNT-1 studied tirzepatide, in different trials with different designs.⁹² Setting their averages side by side as though they were head-to-head would be misleading. SURMOUNT-5 is the first large head-to-head trial; a prescriber can explain how it applies to you.

Our live Mounjaro prices are on the product page, and the first Wegovy pen is £99.99 as a first-order price on the Wegovy pen page.

If you are weighing the two seriously, the useful questions are about your health history, tolerance, and what a prescriber recommends, not which name sounds familiar. Switching between them is a clinical decision, not a rename. Mounjaro must not be combined with other GLP-1 medicines, so you would stop one before starting the other under a prescriber's guidance.¹

For a full list of how these medicines are grouped and labelled, see our overview of GLP-1 names.

06 · Liraglutide, tablets and newer drugs

Liraglutide, tablets and newer medicines

Other weight-management medicines you may see mentioned are different drugs entirely, so none of them is an alternative name for tirzepatide. Knowing what each is helps you avoid mixing up products when you read forums, news or pharmacy listings.

Liraglutide, sold as Saxenda and in products such as Erly, is supplied at a concentration of 6mg per millilitre. It is a daily injection, unlike once-weekly Mounjaro and Wegovy. The difference in schedule alone shows it is a separate product with its own instructions.

There are also tablet forms in the same broad family. Wegovy tablets are an oral semaglutide product, and Foundayo is a different tablet medicine whose active ingredient is orforglipron.²⁰²¹ Both are described in their own product information. They are not names for Mounjaro, and results from their trials should never be read as results for Mounjaro.

Retatrutide is another name that circulates online. It has no UK licence. It should not be treated as a newer brand of Mounjaro, nor as something that can be added to it. The warning is clear: Mounjaro must not be combined with unlicensed 'research' peptides such as retatrutide because there is no safety data and no regulated supply chain.¹

Medicines in development are better referred to by generic names only, because brand names may change before any licence is granted. If you see a trade-sounding name for a medicine that is not yet licensed in the UK, treat it with suspicion.

A simple rule for sorting all of this: a different active ingredient means a different medicine, whatever the marketing says. If the ingredient is tirzepatide and the product is a genuine KwikPen supplied through a regulated pharmacy, it is Mounjaro. Everything else is something else.

When people ask what drug is the same as Mounjaro, the honest answer is that nothing licensed in the UK is identical. Others in the same family work in related ways, but none has the same dual GIP and GLP-1 action. Our page on Mounjaro other options sets out the realistic alternatives and why a prescriber would choose one over another.

You can also read about how Mounjaro interacts with other treatments on our page about Mounjaro and other medications, which is a different question from what it is called.

07 · Research peptides and compounded copies

Research peptides and compounded copies: not alternative names

Products sold as 'tirzepatide peptide', 'research tirzepatide' or compounded tirzepatide are not licensed alternative names for Mounjaro. They are unlicensed copies, and Mounjaro must not be combined with them. These combinations have no safety data and no regulated supply chain.¹

It helps to understand why this matters. A licensed pen is made to a specification, filled and tested under regulated conditions, labelled with batch and expiry information, and supplied through a registered pharmacy after a consultation. A vial sold as a 'peptide' offers none of that. You cannot confirm what it contains, how strong it is, or how it has been stored.

A listing may mention tirzepatide many times and still not be a medicine. If it describes itself as 'for research use only' while hinting at personal use, that mismatch is itself a warning.

Signs that a seller is not legitimate include offering to supply without a consultation or prescription, dramatic weight-loss claims, pressure to buy quickly, and no verifiable pharmacy registration. A UK pharmacy should appear on the GPhC register, and you can check ours (GPhC 9012878) on the GPhC public register.¹²

The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme, where you can report suspected side effects or suspect products.⁷¹⁹ If you have already used something you now doubt, speak to your prescriber or pharmacist and report it.

'Stacking' is a related problem. Online communities sometimes talk about layering several injectables to chase faster results. If something promises faster results outside a licensed pathway, that is the warning sign.¹ A prescriber who knows your history is the right person to talk to about progress, not a seller.

With a genuine service, the path is simple. A free online consultation is reviewed by a GPhC-registered prescriber. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Dispatch is same day when ordered by 3pm, with free next-day tracked delivery in temperature-controlled packaging. That is the contrast with an unregulated seller: a named pharmacy, a review, and a traceable product.

The takeaway for naming is straightforward. The legitimate alternative names are tirzepatide and Mounjaro. Anything else claiming to be the same thing needs verifying before you go near it.

08 · Nicknames and natural 'alternatives'

Nicknames, 'poor man's Ozempic' and natural alternatives

'Poor man's Ozempic' and 'nature's Ozempic' are marketing nicknames for low-cost supplements, not other names for any prescription medicine. They are not Mounjaro, not tirzepatide and not semaglutide. They are sold cheaply without assessment and with no clinical oversight.

These nicknames are used because Ozempic became a household word. Berberine is the best-known example. Sellers borrow the name to imply a comparable effect, but a catchy comparison does not make a supplement a medicine.

The same goes for the question 'What drink works like Ozempic?' or 'How can I mimic Ozempic naturally?'. No drink reproduces what a prescription GLP-1 or GIP and GLP-1 medicine does. Tirzepatide acts on two named gut-hormone receptors to affect appetite, stomach emptying and the body's response to insulin.¹ A beverage or capsule marketed as a natural mimic has not been shown to do the same, and dramatic weight-loss claims attached to such products are a red flag.

That does not mean food and lifestyle are irrelevant. Quite the opposite: treatment with Mounjaro works alongside a reduced-calorie diet and increased physical activity, not instead of them.² In the SURMOUNT-1 trial, lifestyle changes alone produced an average loss of 3.1% over 72 weeks, which is a reminder that diet and activity are part of every approach, with or without medication. Trial averages do not predict your own result.

People often ask which weight loss pill or injection is best, but no licensed medicine is best for everyone. Suitability depends on your health, your history and what you can tolerate. A prescriber is the right person to decide.

If you have a new symptom on treatment, tell your prescriber and report it via the Yellow Card scheme.¹⁹

In short, nicknames are about branding. If you want a regulated option, you want a licensed medicine supplied through a registered pharmacy. For a clear map of the real options, start with our weight loss clinic page.

09 · NHS, labels and checking the name

NHS supply, labels and how to check you have the real thing

Whether you get it on the NHS or privately, you should see the same two names: Mounjaro and tirzepatide. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

The NHS and private pharmacies use the same medicine, so there is no 'NHS brand' versus 'private brand'. The difference is who prescribes it and who pays. For the NHS patient information on the medicine, see the NHS tirzepatide page.⁵

Now, how do you check what you hold? Start with the box and the pen label. A genuine product will show Mounjaro, the active ingredient tirzepatide, the strength (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg or 15mg), and a batch and expiry date. The patient information leaflet should be inside, and it is the authority on storage and use.¹³

Store unopened pens in the fridge until first use. They keep until the printed expiry date. Once in use, a pen can be kept for up to 30 days (not above 30°C). If anything about a pen looks wrong, such as damaged packaging or an unfamiliar label, do not use it and contact the pharmacy that supplied it.

Next, check the supplier. A UK pharmacy should be on the GPhC register. A genuine service will want a consultation, with your answers reviewed by a GPhC-registered prescriber, before anything is dispensed. We also include needles, a sharps bin and injection guidance with every order, and ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team. Repeat orders re-check suitability, with no auto-shipping.

Finally, think about cost in a sensible way. Prices are shown live: if you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices, with a new customer's first order £40 less and every later order £25 less. A first year costs £2,711.88 if you settle at 5mg, up to £3,599.88 at 15mg, before discounts. Prices were checked 10 October 2026.

If you have questions about how Mounjaro fits with your other treatments, our guide on whether you can take Mounjaro with other medications goes through what to tell your prescriber.